Clinical Trial Update: Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Radium-223 dichloride with Abiraterone acetate versus placebo with Abiraterone acetate in chemo-naïve metastatic castration-resistant pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Xofigo (radium-223 dichloride)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Bayer | Conditions: Prostatic Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2019-03-05